Daniel Klamer, PhD, MBA

vice President, Business Development & Scientific Strategy at Anavex Life Sciences

Daniel Klamer, PhD, MBA is the Vice President of Business Development & Scientific Strategy at Anavex Life Sciences. With a background in pharmacology and neuroscience, Daniel has played key roles in various companies, from co-founding startups to leading research projects. Known for their expertise in drug development and commercialization, Daniel has made significant contributions to the field of neurodegenerative and neurodevelopmental diseases.

Links

Org chart

Manager

Stephan Toutain

Senior Vice President of Operations

Peers

Daniel Klamer

Vice President of Business Development and Scientific Strategy

Steven P. Neilson

Vice President Clinical Operations

Clint Tomlinson

Vice President Operations

Reports

James T.

Associate Director Of Clinical Research

Katherine Barnes Madden

Senior Medical Science Liaison

Nell Rebowe

Director of Business Development

Timeline

vice President, Business Development & Scientific Strategy
June, 2017 - present
Senior Director of Business Development
September, 2015

View in org chart